Profile for Japan Patent: 2024520370
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 2024520370
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 11,752,129 | May 27, 2042 | Amgen Inc | OTEZLA XR | apremilast |
| 11,969,409 | May 27, 2042 | Amgen Inc | OTEZLA XR | apremilast |
| 12,427,136 | May 27, 2042 | Amgen Inc | OTEZLA XR | apremilast |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
